Read + Share
Amedeo Smart
Independent Medical Education
Berardicurti O, Pavlych V, Cola ID, Ruscitti P, et al. Long-term Safety of Rituximab in Primary Sjogren Syndrome: The Experience of a Single Center. J Rheumatol 2022;49:171-175.PMID: 34654730
Email
LinkedIn
Facebook
Twitter
Privacy Policy